main difference between semaglutide and tirzepatide GLP-1 Vs Zepbound For Weight Loss Comparison of tirzepatide versus semaglutide

However, none were willing to take the risk with a drug derived from the dangerous lizard

They share the same main ingredient but are approved for different uses and have unique pros and cons for weight loss

However, the authors of this study noted that there were no clinically significant differences, and both drugs were effective for their intended uses

Because it has not yet received MHRA or EMA marketing authorisation, its full safety profile particularly beyond 48 weeks is still being established

and received speakers fees from Boehingher Ingelheim (20212025), Novo Nordisk (20212025), Eli Lilly (2022) and Servier (2021)

Some patients continue GLP-1 therapy long-term at a maintenance dose to support sustained weight loss